首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷內視鏡檢查設備

市場調查報告書

商品編碼

1319133

全球內視鏡後處理市場 - 2023-2030 年

Global Endoscope Reprocessing Market - 2023-2030

出版日期: 2023年07月31日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

2022 年，全球內視鏡後處理市場規模達到23 億美元，預計到2030 年將達到45 億美元，2023-2030 年的年均複合成長率為9.2%。）醫療保健意識的增強、技術的進步（如整合連接功能、數據追踪和遠程監控功能）推動了內視鏡再處理市場需求的成長趨勢。

內視鏡再處理對於預防感染方法和確保醫療操作過程中的患者安全至關重要。內視鏡再處理對於確保有效清除污染和降低醫療相關疾病的風險至關重要。超音波清洗器、消毒器、清洗消毒器、乾燥和儲存櫃、內視鏡追踪系統以及其他解決方案都包括在市場中。

全球內視鏡後處理市場的範圍包括產品類型、高級消毒劑和試紙、清潔劑和濕巾、自動內視鏡後處理器、內視鏡乾燥、存儲和運輸系統等，這些產品的使用增加了內視鏡後處理的市場佔有率。

全球內視鏡後處理市場不斷擴大的因素包括：醫療相關感染（HAI）發病率上升、內視鏡手術數量增加、患者安全日益受到重視、微創手術日益受到青睞以及老年人口不斷增加。

市場動態

老年人口的增加預計將推動內視鏡後處理市場的成長

預計不斷成長的老年人口將推動內視鏡後處理行業向前發展。隨著老年人口的成長，對內視鏡手術等醫療服務的需求也在成長。老年病人經常需要更定期的醫療檢查和診斷程序，包括使用內視鏡。內視鏡再處理對於確保這些程序的安全性和有效性至關重要。

例如，根據世界衛生組織（WHO）2022 年的報告，到2030 年，地球上每六個人中就有一個是60 歲或以上的老人。在這一時間跨度內，世界60 歲及以上人口的比例預計將從2020 年的10 億增加到14 億。因此，不斷成長的老年人口增加了對內視鏡再處理的需求，推動了市場的發展。

對微創手術日益成長的偏好是全球內視鏡後處理市場的主要驅動力

與傳統手術技術相比，微創手術具有顯著優勢，因此越來越受歡迎。這些優勢包括減少不適感、縮短住院時間、減少問題、減少疤痕和組織損傷。影響患者、醫療服務提供商和整個行業的各種因素推動了微創手術的日益普及。內視鏡再處理是實現微創手術的關鍵。內視鏡消毒可通過人工或機器完成。

腹腔鏡微創手術的增加是推動市場發展的主要因素。例如，根據克利夫蘭診所組織2022 年的文章，全球每年進行1300 萬例腹腔鏡手術。預計在未來五年內，這些數位還將成長1%。隨著微創手術需求的成長，對有效、可靠的內視鏡再處理解決方案的要求也隨之提高。

缺乏合格的專業人員將阻礙市場成長

缺乏合格的專業人員來有效監控內視鏡後處理設備是一個關鍵的商業限制因素。對這些系統進行適當的監控和維護是確保內視鏡成功消毒和滅菌的關鍵。然而，設備的複雜性和操作所需的專業知識對合格的專業人員產生了需求。

這類技術人員的短缺會給系統性能、遵守安全規定和保證病人安全帶來問題。解決這一短缺問題以及為技術人員提供適當的培訓和資源，是克服這一制約因素和支持擴大內視鏡再處理業務的關鍵組成部分。

COVID-19 影響分析

COVID-19 大流行對內視鏡後處理市場產生了重大影響，人們更加重視感染預防和控制方法。個人防護設備需求的增加以及供應鏈問題影響了後處理設備和用品的供應和成本。內視鏡手術和病人數量的變化，特別是非急診手術的推遲，影響了對再處理服務的需求。

遠程醫療和遠程監控的使用增加了對新型再處理解決方案的需求。醫療機構已將衛生和再處理實踐列為優先事項，如改進清潔、員工培訓和監控。

例如，美國國家醫學圖書館2021 年發表的一篇文章指出，為確保內視鏡的安全再處理，建議採取某些預防措施，包括手套、防護服、面罩和其他設備。這主要強調了在不久的將來行業發展對這些措施的需求。總之，COVID-19 大流行需要不斷提高警惕並進行修改，以確保整個內視鏡手術過程中的患者安全。

俄烏戰爭影響分析

俄羅斯和烏克蘭之間的持續衝突對內視鏡再處理行業產生了相當大的影響。入侵和由此引發的事件給供應鏈造成了障礙，導致元件短缺、物流挑戰和成本增加。

這些困難再加上通貨膨脹壓力，影響了醫療客戶的財務狀況。此外，大流行病的持續影響也減緩了醫療服務的恢復速度，尤其是擇期手術。在這種環境下，提高醫療生產力變得越來越重要，而內視鏡再處理領域的智慧產品和服務有助於滿足這一需求。

Market Overview

The Global Endoscope Reprocessing Market reached US$ 2.3 billion in 2022 and is expected to reach US$ 4.5 billion by 2030 growing with a CAGR of 9.2% during the forecast period 2023-2030). The growing awareness of healthcare, advancement in technologies such as integration of connectivity features, data tracking, and remote monitoring capabilities are driving up demand for endoscope reprocessing market trends.

Endoscope reprocessing is critical in infection prevention methods and for ensuring patient safety during medical operations. Endoscope reprocessing is critical for guaranteeing effective contamination removal and lowering the risk of healthcare-associated illnesses. Ultrasonic washers, sterilizers, washer disinfectors, drying and storage cabinets, endoscope tracking systems, and other solutions are included in the market.

The global endoscope reprocessing market scope comprises components encompassing product types, high-level disinfectants and test strip, detergents and wipes, automated endoscope reprocessors, endoscope drying, storage, and transport systems which has increased usage of endoscope reprocessing market share.

The global market for endoscope reprocessing is expanding as a result of factors including rising prevalence of healthcare-associated infections (HAI's), increasing number of endoscopic procedures, increasing focus on patient safety, increasing preference for minimally invasive surgeries, and growing geriatric population.

Market Dynamics

Rising Geriatric Population is Estimated to Drive the Growth of the Endoscope Reprocessing Market

The growing geriatric population is projected to propel the endoscope reprocessing industry forwards. As the older population grows, so does the demand for healthcare services such as endoscopic procedures. Geriatric patients frequently require more regular medical examinations and diagnostic procedures including the use of endoscopes. Endoscope reprocessing is critical to ensuring the safety and effectiveness of these procedures.

For instance, according to World Health Organization (WHO) 2022 report, by 2030, about one out of every six people on the planet will be 60 or older. Within this time span, the share of the world population aged 60 and up is expected to increase from 1 billion in 2020 to 1.4 billion. As a result, the growing elderly population adds to an increased demand for endoscope reprocessing, propelling the market forwards.

Rising Preference toward Minimal Invasive Procedures is the Major Driver in the Global Endoscope Reprocessing Market

Minimally invasive operations are becoming increasingly popular due to their significant advantages over traditional surgical techniques. These advantages include less discomfort, shorter hospital stays, fewer problems, less scarring, and less tissue damage. The growing popularity of minimally invasive surgeries is being driven by a variety of factors affecting patients, healthcare providers, and the industry as a whole. Endoscopic reprocessing is critical in enabling minimally invasive operations. Endoscope disinfection can be done manually or using machines.

The rising laproscopic minimal invasive surgeries is major factor to drive the market. For instance, according to Cleveland Clinic organization 2022 article, every year, 13 million laparoscopic surgeries are performed worldwide. These figures are expected to rise by 1% during the following five years. As the need for minimally invasive surgeries grows, consequently rises the requirement for effective and dependable endoscopic reprocessing solutions.

Lack of Qualified Professional will Hamper the Growth of the Market

The lack of qualified professionals to effectively monitor endoscopic reprocessing equipment is a key commercial limitation. The appropriate monitoring and maintenance of these systems are critical to ensuring successful disinfection and sterilization of endoscopes. However, the complexity of the equipment and the specialized expertise necessary for its operation creates a demand for qualified specialists.

The shortage of such technicians causes issues in terms of system performance, compliance with safety regulations, and guaranteeing patient safety. Addressing this shortfall, as well as providing proper training and resources for technicians, are critical components in overcoming this constraint and supporting the expansion of the endoscopic reprocessing business.

COVID-19 Impact Analysis

The COVID-19 pandemic had a major effect on the endoscope reprocessing market, with a greater emphasis on infection prevention and control methods. Increased demand for personal protection equipment, as well as supply chain problems, have impacted the availability and cost of reprocessing equipment and supplies. Endoscopy procedures and patient volume change, especially the deferral of non-urgent operations, have influenced the demand for reprocessing services.

The use of telemedicine and remote monitoring has increased the demand for novel reprocessing solutions. Healthcare facilities have prioritized hygiene and reprocessing practices, such as improved cleaning, employee training, and monitoring.

For instance, according to National Library of Medicine article published in 2021, stated that to ensure the safe reprocessing of endoscopes, certain precautions, which include gloves, gowns, face shields, and other equipment, are advised. That mainly, emphasizes the need for such measures for the industry's growth in the near future. Overall, the COVID-19 pandemic has required constant vigilance and modification to guarantee patient safety throughout endoscopic procedures.

Russia-Ukraine War Impact Analysis

The ongoing conflict between Russia and Ukraine has had a considerable impact on the endoscope reprocessing sector. The invasion and resulting events have produced hurdles in the supply chain, resulting in component shortages, logistical challenges, and increased costs.

These difficulties, combined with inflationary pressures, have impacted the financial status of healthcare clients. Furthermore, the pandemic's continued impacts have slowed the recovery of healthcare services, notably elective surgeries. Improving healthcare productivity has become increasingly crucial in this environment, and smart products and services in the field of endoscope reprocessing can help to meet this demand.

Segment Analysis

The global endoscope reprocessing market is segmented based on product, end user and region.

Hospitals Segment Accounts for 41.1% of Market Share Owing to the Usage of Endoscopic Devices

Hospitals are important consumers of endoscopes, using them in a variety of diagnostic and therapeutic procedures such as gastrointestinal, urological, and pulmonary interventions. Because of the high volume of surgical procedures performed in hospitals, there is an elevated danger of cross-contamination and the spread of infections. To overcome this issue, hospitals are widely implementing sterilizers, automated endoscope reprocessors, and other advances in technology.

For instance, in April 2023, Children's Hospital Los Angeles (CHLA) became the first healthcare centre in California to use the EvoEndo Single-Use Endoscopy System for diagnostic unsedated TNE procedures of the Upper Gastrointestinal (GI) Tract. So to assure the safety and effectiveness of endoscopic treatments, they prioritize the use of efficient and dependable reprocessing methods. Endoscope cleaning, disinfection, and sterilization are handled by dedicated reprocessing departments or facilities equipped with specialized equipment and well-trained people.

Furthermore, hospitals exhibit a commitment to preventing cross-contamination and infections by striving to maintain strict reprocessing procedures and standards. The hospital segment's dominance in the endoscope reprocessing market can be ascribed to the large volume of endoscopic procedures conducted in hospitals, as well as their continuous commitment to patient safety and infection control. Thus, owing to the above factors the segment is expected to grow over the forecast period.

Geographical Analysis

North America Accounted for Approximately 39.3% of the Market Share Owing to the Increasing Collaborations

North America is likely to maintain its dominant position in the market due to increased investments and collaborations. The region's hostile commitment to encouraging breakthroughs and developments in endoscope reprocessing technology has garnered considerable investments from industrial players and academic organizations. Collaborations between healthcare providers, manufacturers, and regulatory authorities have also contributed to the market's rise.

For instance, in January 2023, AA Medical, a company dedicated to providing sustainable solutions for the new and resale medical device equipment sectors, announced a successful collaboration with Certified Endoscopy Products, a well-known medical device reprocessing company situated in Chicago. This collaboration seeks to gain a dominant market position by delivering high-quality reprocessing services for endoscopic equipment, as well as catering to the orthopedic and other surgical device sectors. Thus owing to the above factors the region is expected to dominate the market over the forecast period.

Competitive Landscape

The major global players in the endoscope reprocessing market include: Cantel Medical, Ecolab Inc, STERIS plc., Olympus Corporation, Getinge AB, Belimed AG , CONMED Corporation, Laboratoires Anios, SciCan Inc., HOYA Corporation, among others.

Why Purchase the Report?

To visualize the global endoscope reprocessing market segmentation based on product, end user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of endoscope reprocessing market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global endoscope reprocessing market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by End User
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Geriatric Population
  - 4.1.1.2. Rising Preference toward Minimal Invasive Procedures
- 4.1.2. Restraints
  - 4.1.2.1. Lack of Qualified Professional
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. High-Level Disinfectants and Test Strips*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Detergents and Wipes
7.4. Automated Endoscope Reprocessors
7.5. Endoscope Drying, Storage, and Transport Systems
7.6. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgery Centers
8.4. Other

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. U.K.
  - 9.3.5.3. France
  - 9.3.5.4. Spain
  - 9.3.5.5. Italy
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Cantel Medical*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Ecolab Inc
11.3. STERIS plc.
11.4. Olympus Corporation
11.5. Getinge AB
11.6. Belimed AG
11.7. CONMED Corporation
11.8. Laboratoires Anios
11.9. SciCan Inc.
11.10. HOYA Corporation

LIST NOT EXHAUSTIVE